Prolonged-release opioid for recovery

Not Applicable

• Conditions: Patient participants prescribed a buprenorphine formulation by NHS Tayside Drug and Alcohol Recovery Services for their opioid dependence; Mental and Behavioural Disorders; Mental and behavioural disorders due to use of opioids

• Registration Number: ISRCTN27693404
• Lead Sponsor: HS Tayside

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-28
• Last Update Posted: 19 February 2024
• Study Completion: 2025-07-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 57

Inclusion Criteria

1. Adult (aged 18 years or over) males and females
2. History of problematic substance abuse
3. Treated in NHS Tayside with either Buvidal (prolonged-release buprenorphine) or sublingual/oral lyophilisate buprenorphine
OR
4. A member of the multidisciplinary alcohol and drug recovery service team in NHS Tayside (staff participant only)
AND
5. People of any ethnic origin who are able to speak English and are willing to talk about and reflect on their experiences with the phenomenon under study
6. Willing to have the semi-structured interviews audio recorded
7. Able to give informed consent

Exclusion Criteria

1. Individuals will not be enrolled on the study if they are participating in the clinical phase of another interventional study or have done so within the last 30 days
2. Individuals who are participating in the follow-up phase of another interventional trial/study, or who are enrolled in an observational study, will be co-enrolled where the CIs of each study agree that it is appropriate

Study & Design

• Study Type: Observational
• Study Design: Not specified